Press Releases

Distributed: April 23, 2009

Alerts Login

Share on StockTwits  
Melbourne, April 23, 2009 (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that it had received notification from GlaxoSmithKline (LON:GSK) that Relenza sales were A$462 million and indicative royalties were A$32.3 million, for the three months ended 31 March 2009.

Indicative royalties for the nine months to 31 March 2009 total A$36.1 million.

Biota CEO Peter Cook attributed the performance to recent significant orders for pandemic stockpiling from the UK and Japanese Governments.

Share on StockTwits  


Investor / Analyst Enquiries
Biota Holdings Limited
Peter Cook
Tel: +61-3-9915-3720

Damian Lismore
Tel: +61-3-9915-3721

  Related Companies

>>>         Biota Holdings Limited
>>>        GlaxoSmithKline plc

  Related Industry Topics:

Biotech | Drugs & OTC | Health & Pharm General | 

  This Page Viewed:  (Last 7 Days: 7) (Last 30 Days: 68) (Since Published: 6856) 


  ABN Newswire on Social Media

Site Search

 ENGLISH   All Languages
Send A Press Release
Webcast Your Annual General Meeting

Mobile Video TV

Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile